Hormone replacement therapy and the risk of ovarian cancer

被引：11

作者：

Risch, HA ^{[1
]}

机构：

[1] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA

来源：

GYNECOLOGIC ONCOLOGY | 2002年 / 86卷 / 02期

关键词：

D O I：

10.1006/gyno.2002.6774

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：115 / 117

页数：3

共 37 条

[1] RISK OF CANCER IN WOMEN RECEIVING HORMONE REPLACEMENT THERAPY [J].

ADAMI, HO ;

PERSSON, I ;

HOOVER, R ;

SCHAIRER, C ;

BERGKVIST, L .

INTERNATIONAL JOURNAL OF CANCER, 1989, 44 (05) :833-839

[2]

ANNEGERS JF, 1979, CANCER, V43, P723, DOI 10.1002/1097-0142(197902)43:2<723::AID-CNCR2820430248>3.0.CO

[3]

2-1

[4] RISK-FACTORS FOR OVARIAN-CANCER - A CASE CONTROL STUDY [J].

BOOTH, M ;

BERAL, V ;

SMITH, P .

BRITISH JOURNAL OF CANCER, 1989, 60 (04) :592-598

[5]

Cramer Daniel W., 1995, Annals of Epidemiology, V5, P310, DOI 10.1016/1047-2797(94)00098-E

[6]

CRAMER DW, 1983, JNCI-J NATL CANCER I, V71, P711

[7]

CRAMER DW, 1983, JNCI-J NATL CANCER I, V71, P717

[8] ESTRADIOL STIMULATES CELL-GROWTH AND SECRETION OF PROCATHEPSIN-D AND A 120-KILODALTON PROTEIN IN THE HUMAN OVARIAN-CANCER CELL-LINE BG-1 [J].

GALTIERDEREURE, F ;

CAPONY, F ;

MAUDELONDE, T ;

ROCHEFORT, H .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (06) :1497-1502

[9]

HALME J, 1984, OBSTET GYNECOL, V64, P151

[10]

HARLOW BL, 1988, CANCER RES, V48, P5849

← 1 2 3 4 →